Agenda

Hosted by:

The concept of "art and science" is important because one of the hardest, and most important things CEOs need to do is knowing when, as well as who should, and how to evolve the team during the different stages without losing momentum, and positively vs. negatively affecting the close-knit culture of small teams.  In the early R&D stages of a venture-backed company, the environment, milestones and processes are different than what is required during the clinical study and commercialization stages.  Often times, people who are best suited for the early stages may not be as effective in later stages & vice versa. We'll also discuss the "will" of leaders as it relates to building solid and cohesive company cultures.

Through Q&A, stories, examples, and humor, we'll follow a sequential process of hiring that will resonate with CEOs leading venture-backed, small-to-mid size, and  large MedTech companies:

• Pursuing, Attracting and Assessing talent
• Developing & Retaining Talent
• Stretching & Promoting Top Talent

Facilitator:
Julie Allen
Founder, Managing Partner
Allen Executive Search

Participants:
Bob Paulson
President & CEO
NxThera

Jeff Mirviss
President, Peripheral Interventions
Boston Scientific

Matt Likens
President & CEO
Ulthera

Speaker:
Mark Scholtes
Partner
PricewaterhouseCoopers

Under the Microscope: Venture Capital Investing in the Medical Device Market

Speaker:
David Coats
Managing Director
Correlation Ventures

Which business profile is best suited to this challenging environment for medtech?

Co-Moderators:
Gregory Grunberg MD
Managing Director
Longitude Capital

Patrice Kloss
Partner
Oppenheimer Wolff & Donnelly

Panelists:
Michael J. Wasserman
Managing Director
H.I.G. BioVentures

Noah Lewis
Managing Director
GE Ventures

Kirk Nielsen
Managing Director
Versant Ventures

Josh Baltzell
Managing Director
Split Rock Partners

Jonathan Silverstein
General Partner
OrbiMed Advisors

Guido Neels
Managing Director
Essex Woodlands

Moderator:
William Harrington
Managing Partner
Osage University Partners

Panelists:
Buzz Benson
Managing Director
SightLine Partners

Mike Carusi
Managing Director
Advanced Technology Ventures

Chad Cornell
Vice President, Corporate Development
Medtronic

Todd Davis
Founding Managing Director
HealthCare Royalty Partners

Medtech has traditionally gone from relatively small proof of concept registries directly to a pivotal randomized PMA study, perhaps prematurely and prior to gaining a better understanding of the product’s capabilities or performance. This panel will discuss where and when it makes sense to pursue a two-step vs. three-step approach to improve success rates on the pivotal study. The implications of the three step approach for the overall development timeline and financing challenges will also be explored.

Moderator:
Dennis Wahr
President & CEO
Holaira

Panelists:
Edward S. Andrle
Vice President, Business Development & Strategy
Sorin Group

Rajeev Dadoo, PhD
Partner
SR One

Lisa Earnhardt
President & CEO
Intersect ENT

Kevin Hykes
Executive Chairman
Metavention, Inc.

Evan Norton
Director Venture Investments
Abbott Ventures

David Neustaedter
Vice President
Covidien Ventures

Speaker:
Carla Kikken-Jussen
VP Medical Devices, Europe
Medpace Medical Device

MedTech Lifetime Innovator Award Presentation

Award Recipient:
Dale Spencer
Managing Director
JDC Spencer Investment Co., LLLP

Presented by:
Thomas Letscher
Chairman
Oppenheimer Wolff & Donnelly

Keynote Presentation
Covidien’s acquisition strategy and perspective on how medtech companies are adapting to the changing environment

Guest Speaker:
Stacy Enxing Seng
President, Vascular Therapies
Covidien

Speaker:
Dale Wahlstrom
President & CEO
LifeScience Alley & BioBusiness Alliance of Minnesota

Interviewer:
Mark Leahey
President
MDMA

Interviewee:
Jeffrey E. Shuren, M.D., J.D.
Director, Center for Devices and Radiological Health
FDA

The America Invents Act has created new opportunities and new pitfalls when it comes to securing, and if necessary, enforcing your patent rights. Some conventional wisdom still applies, but in other ways, it’s a new world. This presentation will cover 7 steps you can take to make sure you retain and fully realize the value of your IP.

Speaker:
Cyrus A. Morton
Partner
Robins, Kaplan, Miller & Ciresi L.L.P

Co-Moderators:
John Stenson FAA, MAAA
Principal
PwC

Lisa Suennen
Managing Member
Psilos Group Managers

Panelists:
Ken Paulus
President & CEO
Allina Health

Edmund Pezalla MD, MPH
National Medical Director, Pharmacy Policy and Strategy
Aetna

Richard Migliori, MD
EVP Health Services
UnitedHealth Group

James W. Eppel, Jr.
Former Chief Operations Officer
BlueCross BlueShield of Minnesota

Moderator:
J.P. Peltier
Managing Director, Healthcare
Piper Jaffray & Co

Panelists:
Chen Yu
Managing Partner, Vivo Ventures
Chief Business Officer, China KangHui (Former)

Luke Harada
Vice President, Business Development
C. R. Bard

Andrea Venturelli
Co-Founder
Invatec

Hosted by: